| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah 84132 [G. A. T.] and the Division of Neurosurgery, Childrens Hospital of Los Angeles and the Department of Neurosurgery, University of Southern California School of Medicine, Los Angeles, California 91011 [C. R.]
The loss of genetic material from specific chromosomal locations in a given tumor type has been taken for evidence of the importance of tumor suppressor genes at these loci in the genesis of the tumor. The primitive neuroectodermal tumor of the central nervous system has such a loss on 17p in one-third of tumors. In this report, a detailed analysis of 17p loss in 23 tumors has been performed using 10 probes mapping to this region. In addition, an analysis for allelic deletion on chromosomes 6q, 16q, and 22q has been performed. Six of the 23 tumors showed loss of markers on 17p, and the area of common loss spanned 17p11.2 to 17pter. Five of 23 tumors showed loss of markers on 6q, and 3 showed loss on 16q. No tumor lost markers on 22q. Only one tumor showed loss at more than one location. These data suggest that primitive neuroectodermal tumors either are a heterogeneous group of tumors with more than one mechanism leading to a tumor or that more than one recessive oncogene may play a role in the genesis of these tumors.
1 This work supported by American Cancer Society Clinical Oncology Career Development Award 89-189 (to G. A. T.).
2 To whom requests for reprints should be addressed, at 1300 N. Vermont Ave., Ste. 906, Los Angeles, CA 90027.
Received 6/21/90. Accepted 10/30/90.
This article has been cited by other articles:
|
|
 |
|
  M. C. Thompson, C. Fuller, T. L. Hogg, J. Dalton, D. Finkelstein, C. C. Lau, M. Chintagumpala, A. Adesina, D. M. Ashley, S. J. Kellie, et al. Genomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations J. Clin. Oncol., April 20, 2006; 24(12): 1924 - 1931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B.Y. Hui, H. Takano, K.-W. Lo, W.-L. Kuo, C. N.Y. Lam, C. Y.K. Tong, Q. Chang, J. W. Gray, and H.-K. Ng Identification of a Novel Homozygous Deletion Region at 6q23.1 in Medulloblastomas Using High-Resolution Array Comparative Genomic Hybridization Analysis Clin. Cancer Res., July 1, 2005; 11(13): 4707 - 4716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Del Valle, J Baehring, C Lorenzana, A Giordano, K Khalili, and S Croul Expression of a human polyomavirus oncoprotein and tumour suppressor proteins in medulloblastomas Mol. Pathol., October 1, 2001; 54(5): 331 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jackson, P. Carrara, V. Duke, P. Sinclair, M. Papaioannou, C. J. Harrison, and L. Foroni Deletion of 6q16-q21 in Human Lymphoid Malignancies: A Mapping and Deletion Analysis Cancer Res., June 1, 2000; 60(11): 2775 - 2779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kappler, T. Pietsch, S. Weggen, O. D. Wiestler, and H. Scherthan Chromosomal imbalances and DNA amplifications in SV40 large T antigen-induced primitive neuroectodermal tumor cell lines of the rat Carcinogenesis, August 1, 1999; 20(8): 1433 - 1438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Packer, P. Cogen, G. Vezina, and L. B. Rorke Medulloblastoma: Clinical and biologic aspects Neuro-oncol, July 1, 1999; 1(3): 232 - 250. [Abstract] [PDF]
|
|
|
|
 |
|
 A. M. Adesma Topical Review: Molecular Heterogeneity in Medulloblastoma With Implications for Differing Tumor Biology J Child Neurol, July 1, 1999; 14(7): 411 - 417. [Abstract] [PDF]
|
|
|
|
|
|
J. A. Biegel Cytogenetics and molecular genetics of childhood brain tumors Neuro-oncol, April 1, 1999; 1(2): 139 - 151. [Abstract] [PDF]
|
|
|
|
 |
|
 G J Hannon, D Demetrick, and D Beach Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes & Dev., December 1, 1993; 7(12a): 2378 - 2391. [Abstract] [PDF]
|
|
|
|
 |
|
 E. M. C. MICHIELS, E. OUSSOREN, M. VAN GROENIGEN, E. PAUWS, P. M. M. BOSSUYT, P. A. VOUTE, and F. BAAS Genes differentially expressed in medulloblastoma and fetal brain Physiol Genomics, August 31, 1999; 1(2): 83 - 91. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
